Ubiquitin: A double-edged sword in hepatitis B virus-induced hepatocellular carcinoma

Arpita Kar1, Sandipan Mukherjee1, Soumyadeep Mukherjee2

  • 1Department of Signal Transduction & Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata, India.

Virology
|August 8, 2024
PubMed

Insights

Ubiquitination plays a dual role in Hepatitis B virus (HBV) infection, influencing both viral progression and host cell transformation. Understanding these ubiquitination events is key to developing new treatments for HBV-induced liver cancer.

Area of Science:

  • Virology
  • Molecular Biology
  • Cancer Research

Background:

  • Hepatitis B virus (HBV) is a major cause of liver cancer and mortality worldwide.
  • Despite existing therapies and vaccines, the precise mechanisms of HBV pathogenesis remain incompletely understood.
  • Novel strategies targeting virus-host interactions are needed to combat HBV-related diseases.

Purpose of the Study:

  • To review the current literature on ubiquitination's role in the Hepatitis B virus (HBV) host-pathogen interactome.
  • To elucidate how ubiquitination events influence HBV infection, replication, and the development of hepatocellular carcinoma (HCC).
  • To highlight potential therapeutic targets for novel anti-HBV and anti-cancer strategies.

Main Methods:

  • Comprehensive literature review of studies investigating ubiquitination in HBV infection and hepatocellular carcinoma.
  • Analysis of research detailing the ubiquitination of both viral and host proteins.
  • Synthesis of findings on the dual role of ubiquitination in restricting or promoting HBV pathogenesis.

Main Results:

  • Ubiquitination significantly impacts the turnover and function of viral and host proteins during HBV infection.
  • Certain ubiquitination events restrict HBV replication and carcinogenesis, while others promote hepatocarcinoma development.
  • The interplay between HBV and host ubiquitination machinery is crucial for viral persistence and oncogenesis.

Conclusions:

  • Ubiquitination is a critical post-translational modification modulating the host-HBV crosstalk.
  • Targeting specific ubiquitination pathways offers potential for developing new therapeutic interventions against HBV-induced liver cancer.
  • Further research into ubiquitination dynamics can lead to novel strategies for controlling HBV-related hepato-carcinogenesis globally.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K